Table 2.

Description of primary and competing outcomes in the study population of 161 renal transplant recipients with IgA nephropathy as underlying disease leading to TX

Follow-up information
Median follow-up time (years) [IQR]	7.1 [5.7, 9.2]
Primary outcome
Recurrence of IgA nephropathy, N (%)	43 (26.7%)
- median time from TX to IgAN recurrence (months) [IQR]	8.5 [3.2, 12.8]
- graft failure / death post IgAN recurrence, N (%)	6 (14%) / 4 (9.3%)
Median time to graft failure or death post IgAN recurrence (years) [IQR]	4.8 [1.4, 6.5]
Competing (recurrence-free) outcomes
Median recurrence-free time to death or graft failure [IQR]	6.7 [5.4, 8.6]
- graft failure, N (%)	6 (3.7%)
- death, N (%)	6 (3.7%)

Abbreviations:TX transplantation, IQR interquartile range, IgAN IgA nephropathy